The Botín Foundation and the University join forces to promote new advanced cancer therapies

The Botín Foundation Foundation and the University of Navarra, through the Clínica Universidad de Navarra and the Cimaits biomedical research center , have signed an agreement with the agreement to promote the development of new advanced therapies against blood cancers. This partnership aims to transfer the laboratory 's scientific advances to clinical internship offering other options to treat complex hematological diseases such as leukemias, lymphomas and myeloma.

CAR-T therapy: a hope for patients with no alternatives

This agreement focuses on CAR-T cell therapy, a promising technique that has shown positive results in clinical trials. This treatment consists of extracting immune cells from the patient, genetically modifying them in the laboratory to attack tumor cells more precisely and reintroducing them into the body.

One of the initial core topic projects included in the agreement is TranspoCART19, a treatment against the CD19 protein, present in certain types of lymphoma and B-lymphocyte leukemias. "This technology is currently in the clinical essay phase, evaluating its safety and efficacy in patients whose disease has been resistant to other treatments. With this new strategy we are seeking to attack cancer with greater precision," says Dr. Felipe Prósper, director of the Cell Therapy area at the Clínica Universidad de Navarra, who is leading the project together with Dr. Juan Bueren, director of the Biomedical Innovation Unit at CIEMAT.

From research to clinical application

The goal of this alliance is to ensure that scientific advances reach patients as soon as possible. "This partnership is a core topic for transforming scientific discoveries into real solutions," says Paloma Grau, Vice President of research and Sustainability at the University of Navarra. Iñigo Sáenz de Miera, director General of the Botín Foundation, emphasizes that "the commitment to biomedical innovation strengthens the connection between research and industry, accelerating the arrival of new treatments on the market".

With an initial duration of four years, this agreement seeks to consolidate Spain as a benchmark in biomedical innovation and to foster the partnership between the academic and private sectors to make these advanced treatments accessible to more patients.

About the Botín Foundation

The Marcelino Botín Foundation was created in 1964 by Marcelino Botín Sanz de Sautuola and his wife, Carmen Yllera, to promote the social development of Cantabria. Today, sixty years later, the Botín Foundation contributes to the integral development of society by exploring new ways of detecting creative talent and supporting it in order to generate cultural, social and economic wealth. It is active in the fields of art and culture, Education, science and rural development , and supports social institutions in Cantabria to reach those most in need. The Botín Foundation operates mainly in Spain and especially in Cantabria, but also in Latin America.